All Infection Prevention & Control articles
-
NewsTiny nanocarriers could prove the magic bullet for acne sufferers
A new antibacterial compound was encased in tiny, soft nanoparticles 1000 times smaller than a single strand of human hair and applied in a gel form to targeted acne sites.
-
NewsScientists pioneer dual trojan horse approach to combat superbugs
In the relentless battle against antibiotic-resistant superbugs, science continues to unveil ingenious strategies to address their vulnerability. Like other bacteria, superbugs have a unique weakness – their dependence on iron for growth and survival. Iron serves as an essential nutrient that bacteria utilise for various cellular processes, including DNA replication, ...
-
NewsLeading scientists issue ‘gain of function’ recommendations
A workshop of leading scientists has reviewed the benefits and risks of ’gain of function’ research, and proposed a foundation to guide discussions and improve oversight moving forward.
-
NewsSurveillance system detected infection linked to eye drops months before outbreak declared
An infectious diseases surveillance system successfully flagged cases of a drug-resistant infection spread by eye drops months before national public health officials announced an outbreak.
-
OpinionEmerging risks in public health: is plastic pollution something to worry about?
Could plastic waste act as a vector for pathogens and contribute to the spread of infectious diseases?
-
NewsSepsis is as common as cancer, study reveals
A study in Sweden that more than four percent of all hospitalizations involved the patient suffering from sepsis, and 20 percent of all sepsis patients died within three months.
-
NewsDrinking water quality linked to lung infections in people with cystic fibrosis
High levels of some minerals and metals in environmental water supplies may increase the risk of nontuberculous mycobacteria (NTM) pulmonary infections in people with cystic fibrosis, according to a new study.
-
NewsResearchers on cusp of a new vaccine modality breakthrough
Researchers have succeeded in developing a new vaccine modality that is a stable particulate vaccine. The new vaccine modality is at proof-of-concept stage and in early development.
-
NewsGut microbiome can increase risk and severity of HIV and EBV disease
Researchers have shown that the microbiome has a significant impact on the acquisition of Epstein-Barr virus (EBV) and human immunodeficiency virus-1 (HIV) infection and plays a role in the course of disease.
-
NewsAcademic-private partnership aims to reduce toxic effects of deadly C. diff
The Center for One Health Research and Nectagen Inc. have received a nearly $275,000 grant to study whether synthetic proteins developed by Nectagen can reduce the toxicity of the digestive bacterium.
-
NewsMolnupiravir dose of human effect size-equivalent blocks Covid transmission in ferrets
Two oral drugs provide equivalent therapeutic benefit in preventing severe COVID-19 in animal models, but only molnupiravir efficiently blocked SARS-CoV-2 transmission when administered at a human effect size-equivalent dose.
-
NewsModulating type 1 Interferon may expand treatment options for COVID-19
Researchers have, for the first time in nonhuman primates, studied how modulating the signaling of type 1 Interferon (IFN-I), one of the body’s initial defenses against infection, impacts SARS-CoV-2 viral replication and disease progression.
-
NewsResearchers find chink in the armour of tuberculosis pathogen
Discovery of drug resistance network could clear way for developing a drug to prevent pathogen from resisting and tolerating tuberculosis treatment.
-
NewsAMR poses threat in all 35 countries in the Americas
569,000 deaths were linked to bacterial antimicrobial resistance in all 35 countries of the WHO Region of the Americas, according to a new study.
-
NewsNew VDEC is ‘step change’ for UK’s growing vaccine capabilities
The UK Health Security Agency has unveiled its world-leading Vaccine Development and Evaluation Centre at Porton Down, which will be at the forefront of the UK’s ability to develop vaccines against the world’s deadliest pathogens.
-
NewsGene-editing technology eliminates EV-A71 RNA viruses
Scientists have developed a CRISPR-Cas13 therapeutic against EV-A71, the RNA virus that causes hand, foot, and mouth disease.
-
OpinionMe, my microbes and I: rethinking antimicrobial stewardship and personal health education
Research into, and therefore general understanding of women’s health and disease, has been under funded and taboo for a long time.
-
News Researchers discover method to overcome antimicrobial resistance
Scientists have found a new class of molecules that inhibit the efflux pump of a bacterial cell.
-
NewsStudy demonstrates efficacy of new short-term resistant TB treatment
Four patients at Boston Medical Center (BMC) Tuberculosis Clinic were cured of MDR TB with a six-month regimen that included bedaquiline, pretomanid and linezolid (BPaL).
-
NewsSmaller magnetic beads with superior magnetic moment capture Covid virus more quickly
Scientists have developed a more efficient way to test SARS-CoV-2 Virus with a novel nano-immune magnetic bead (Mal-IMB) that can efficiently be bound to the pseudovirus in the study of protein biomimetic mineralization and synthesized into magnetic nanoparticles.
